跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要直接讨论错位政策实施下双重差分的因果识别与已处理者平均处理效应。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Julia C. Thome
Peter F. Rebeiro
Andrew J. Spieker
Bryan E. Shepherd

理解错位实施政策的双重差分:Medicaid 与 HIV 的应用

研究问题
在政策跨多年错位实施时,不同双重差分方法与线性模型有何关系,其识别假设如何影响已处理者平均处理效应?
方法与思路
作者用潜在结果记号说明近期双重差分扩展的识别与估计,并以美国 Medicaid 扩张及 HIV 感染者持续就诊为背景。
材料陈述的贡献
摘要称文章阐明错位实施下不同方法的假设及联系,帮助研究者选择适当方法,避免对较新方法的复杂性产生误解。
阅读关注点
应核对各方法的目标效应、处理批次与对照组选择,以及平行趋势等条件如何表述和用于具体政策应用。
阅读边界
这是 arXiv 预印本,同行评审及接收未核实;摘要未列出具体识别条件或政策效应结果,不能判断哪种方法在应用中成立。

原文摘要

While a randomized control trial is considered the gold standard for estimating causal treatment effects, there are many research settings in which randomization is infeasible or unethical. In such cases, researchers rely on analytical methods for observational data to explore causal relationships. Difference-in-differences (DID) is one such method that, most commonly, estimates a difference in some mean outcome in a group before and after the implementation of an intervention or policy and compares this with a control group followed over the same time (i.e., a group that did not implement the intervention or policy). Although DID modeling approaches have been gaining popularity in public health research, the majority of these approaches and their extensions are developed and shared within the economics literature. While extensions of DID modeling approaches may be straightforward to apply to observational data in any field, the complexities and assumptions involved in newer approaches are often misunderstood. In this paper, we focus on recent extensions of the DID method and their relationships to linear models in the setting of staggered treatment adoption over multiple years. We detail the identification and estimation of the average treatment effect among the treated using potential outcomes notation, highlighting the assumptions necessary to produce valid estimates. These concepts are described within the context of Medicaid expansion and retention in care among people living with HIV (PWH) in the United States. While each DID approach is potentially valid, understanding their different assumptions and choosing an appropriate method can have important implications for policy-makers, funders, and public health as a whole.

笔记与分组
相关领域论文